Table 2.
Summary of stage, chemotherapy and microbiological results
| Only cancer N=108 |
Coexisting granulomatous inflammation with lung cancer N=19 | |
|---|---|---|
| Stage I and II | 84 (77.7) | 13 (68.4) |
| T-1 | 60 (55.5) | 13 (68.4) |
| T-2 | 24 (22.2) | 6 (31.5) |
| N-0 | 10 (9.2) | 3 (15.7) |
| N-1 | 50 (46.2) | 10 (52.6) |
| N-2 | 24 (22.2) | 6 (31.5) |
| Chemotherapy | ||
| Neoadjuvant chemotherapy | 24 (22.2) | 6 (31.5) |
| Concurrent chemoradiotherapy | 27 (25) | 5 (26.3) |
| Epidermal growth factor receptor–tyrosine kinase inhibitor | 7 (6.4) | None |
| Acid-fast bacilli (AFB) culture | ||
| No. of patients in whom AFB cultures done | 27 (25) | 9 (47.3) |
| No. of patients in whom AFB culture was positive | None | 2 (non-tuberculous mycobacteria) |
| No. of patients in whom Ziehl-Neelsen stain done | 108 (100) | 19 (100) |
| No. of patients in whom Ziehl-Neelsen stain was positive for AFB | None | None |
Data presented as number (%).